gadolinium dtpa has been researched along with Emesis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirchin, MA; Parker, JR; Pirovano, G; Shellock, FG; Shen, N; Spinazzi, A; Venetianer, C | 1 |
Akin, ML; Celenk, T; Erenoğlu, C; Top, C; Uluutku, AH | 1 |
2 other study(ies) available for gadolinium dtpa and Emesis
Article | Year |
---|---|
Safety characteristics of gadobenate dimeglumine: clinical experience from intra- and interindividual comparison studies with gadopentetate dimeglumine.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Contrast Media; Fever; Gadolinium DTPA; Hemorrhage; Humans; Magnetic Resonance Imaging; Middle Aged; Risk Assessment; Risk Factors; United States; Vomiting | 2006 |
Do MRI agents cause or worsen acute pancreatitis?
Topics: Abdomen, Acute; Contrast Media; Diagnosis, Differential; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Pancreatitis, Acute Necrotizing; Vomiting | 2007 |